|
1
|
Bile acids increase response and expression of human myometrial oxytocin receptor.
|
Am J Obstet Gynecol
|
2003
|
1.04
|
|
2
|
Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells.
|
Reprod Sci
|
2013
|
0.94
|
|
3
|
Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells.
|
Endocrinology
|
2003
|
0.93
|
|
4
|
TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract.
|
Apoptosis
|
2007
|
0.90
|
|
5
|
Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells.
|
Biomaterials
|
2013
|
0.88
|
|
6
|
The action of ovarian hormones in cardiovascular disease.
|
Biol Res
|
2003
|
0.87
|
|
7
|
Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
|
J Endocrinol
|
2012
|
0.86
|
|
8
|
Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
|
J Cell Physiol
|
2008
|
0.85
|
|
9
|
Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells.
|
J Endocrinol
|
2004
|
0.85
|
|
10
|
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
|
J Biol Chem
|
2012
|
0.84
|
|
11
|
Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
|
J Cell Physiol
|
2011
|
0.82
|
|
12
|
Independent anti-angiogenic capacities of coagulation factors X and Xa.
|
J Cell Physiol
|
2014
|
0.79
|
|
13
|
[In vitro cell response to chemotherapeutic agents, to personalize ovarian cancer treatment: report of two cases].
|
Rev Med Chil
|
2013
|
0.78
|
|
14
|
2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells.
|
Horm Cancer
|
2010
|
0.76
|
|
15
|
In vivo and in vitro estrogenic and progestagenic actions of Tibolone.
|
Biol Res
|
2005
|
0.75
|
|
16
|
Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.
|
Endocrine
|
2014
|
0.75
|